History | Migalastat for treating Fabry disease | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 235 KB)

Published:

22 February 2017

Final evaluation determination

Final evaluation determination
Final evaluation determination document (PDF 417 KB)

Published:

03 January 2017
Committee papers (PDF 517 KB)

Published:

03 January 2017
Public committee slides (PDF 252 KB)

Published:

17 January 2017

Evaluation consultation

Evaluation consultation
Evaluation consultation document (PDF 285 KB)

Published:

18 October 2016
Committee papers (PDF 7.69 MB)

Published:

18 October 2016

Invitation to participate

Equality impact assessment (Scoping) (PDF 122 KB)

Published:

21 January 2016
Final scope (PDF 109 KB)

Published:

21 January 2016
Final matrix (PDF 108 KB)

Published:

21 January 2016
NICE's response to comments on the draft scope and provisional matrix (PDF 162 KB)

Published:

05 July 2016

Draft scope documents

Draft scope (pre-referral) (PDF 114 KB)

Published:

29 January 2016
Provisional matrix (pre-referral) (PDF 109 KB)

Published:

29 January 2016